VRS
OCUL icon

Virginia Retirement Systems’s Ocular Therapeutix OCUL Stock Holding History

Virginia Retirement Systems’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$265K Buy
53,500
+21,300
+66% +$118K ﹤0.01% 1001
2021
Q4 		$224 Buy
32,200
+21,800
+210% +$169K ﹤0.01% 1030
2021
Q3 		$104K Buy
+10,400
New +$117K ﹤0.01% 969

Other funds holding OCUL

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Virginia Retirement Systems's OCUL Position: Q1 2022 in Review

Virginia Retirement Systems increased its Ocular Therapeutix (OCUL) stake by 66% in Q1 2022, buying an estimated $118K and bringing the position to 53,500 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Virginia Retirement Systems first reported a position in OCUL in Q3 2021 and has held it in 3 quarters since. 132 funds tracked by Wall St. Rank hold OCUL as of Q1 2022.

  • Virginia Retirement Systems held 53,500 shares of Ocular Therapeutix worth $265K as of Q1 2022.
  • Virginia Retirement Systems bought 21,300 Ocular Therapeutix shares in Q1 2022, an estimated $118K.
  • Ocular Therapeutix made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q1 2022, its #1001 holding.
  • Virginia Retirement Systems first reported a position in Ocular Therapeutix in Q3 2021 and has held it in 3 quarters since.
  • 132 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.